Intracellular Antiviral Immunity

Advances in Virus Research

Volumn 100, Issue , 2018, Pages 309-354

  Bottermann, Maria ^a   James, Leo C ^a  

^a MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

Author keywords

Innate immunity; PAMPs; PRRs; Signaling; TRIMs

Indexed keywords

PATHOGEN ASSOCIATED MOLECULAR PATTERN; PATTERN RECOGNITION RECEPTOR; TRIPARTITE MOTIF PROTEIN;

ANIMAL; CHEMISTRY; HUMAN; IMMUNOLOGY; IMMUNOMODULATION; INNATE IMMUNITY; INTRACELLULAR SPACE; METABOLISM; SIGNAL TRANSDUCTION; VIROLOGY; VIRUS INFECTION;

ANIMALS; HUMANS; IMMUNITY, INNATE; IMMUNOMODULATION; INTRACELLULAR SPACE; PATHOGEN-ASSOCIATED MOLECULAR PATTERN MOLECULES; RECEPTORS, PATTERN RECOGNITION; SIGNAL TRANSDUCTION; TRIPARTITE MOTIF PROTEINS; VIRUS DISEASES;

EID: 85042130925     PISSN: 00653527     EISSN: 15578399     Source Type: Book Series    
DOI: 10.1016/bs.aivir.2018.01.002     Document Type: Chapter

References (297)

1. Abais, J.M., Xia, M., Zhang, Y., Boini, K.M., Li, P.-L., Redox regulation of NLRP3 inflammasomes: ROS as trigger or effector?. Antioxid. Redox Signal. 22 (2015), 1111–1129.
2. Ablasser, A., et al. RIG-I-dependent sensing of poly(dA:dT) through the induction of an RNA polymerase III-transcribed RNA intermediate. Nat. Immunol. 10 (2009), 1065–1072.
3. Akira, S., Takeda, K., Toll-like receptor signalling. Nat. Rev. Immunol. 4 (2004), 499–511.
4. Allen, I.C., et al. The NLRP3 inflammasome mediates in vivo innate immunity to influenza A virus through recognition of viral RNA. Immunity 30 (2009), 556–565.
5. Allen, I.C., et al. NLRX1 protein attenuates inflammatory responses to infection by interfering with the RIG-I-MAVS and TRAF6-NF-κB signaling pathways. Immunity 34 (2011), 854–865.
6. Allouch, A., et al. The TRIM family protein KAP1 inhibits HIV-1 integration. Cell Host Microbe 9 (2011), 484–495.
7. Almine, J.F., et al. IFI16 and cGAS cooperate in the activation of STING during DNA sensing in human keratinocytes. Nat. Commun., 8, 2017, 14392.
8. Anderson, J.L., et al. Proteasome inhibition reveals that a functional preintegration complex intermediate can be generated during restriction by diverse TRIM5 proteins. J. Virol. 80 (2006), 9754–9760.
9. Arimoto, K., et al. Polyubiquitin conjugation to NEMO by triparite motif protein 23 (TRIM23) is critical in antiviral defense. Proc. Natl. Acad. Sci. U.S.A. 107 (2010), 15856–15861.
10. Barlan, A.U., Griffin, T.M., McGuire, K.A., Wiethoff, C.M., Adenovirus membrane penetration activates the NLRP3 inflammasome. J. Virol. 85 (2011), 146–155.
11. Barr, S.D., Smiley, J.R., Bushman, F.D., The interferon response inhibits HIV particle production by induction of TRIM22. PLoS Pathog. 4 (2008), 1–11.
12. Barral, P.M., Sarkar, D., Fisher, P.B., Racaniello, V.R., RIG-I is cleaved during picornavirus infection. Virology 39 (2009), 171–176.
13. Bharaj, P., et al. The matrix protein of nipah virus targets the E3-ubiquitin ligase TRIM6 to inhibit the IKKɛ kinase-mediated type-I IFN antiviral response. PLoS Pathog. 12 (2016), 1–27.
14. Bidgood, S.R., Tam, J.C.H., McEwan, W.A., Mallery, D.L., James, L.C., Translocalized IgA mediates neutralization and stimulates innate immunity inside infected cells. Proc. Natl. Acad. Sci. U.S.A. 111 (2014), 13463–13468.
15. Bieback, K., et al. Hemagglutinin protein of wild-type measles virus activates toll-like receptor hemagglutinin protein of wild-type measles virus activates toll-like receptor 2 signaling. J. Virol. 76 (2002), 8729–8736.
16. Bottermann, M., et al. Antibody-antigen kinetics constrain intracellular humoral immunity. Sci. Rep., 6, 2016, 37457.
17. Boutell, C., Orr, A., Everett, R.D., PML residue lysine 160 is required for the degradation of PML induced by herpes simplex virus type 1 regulatory protein ICP0 PML residue lysine 160 is required for the degradation of PML induced by herpes simplex virus type 1 regulatory protein ICP0. Society 77 (2003), 8686–8694.
18. Bridgeman, A., et al. Viruses transfer the antiviral second messenger cGAMP between cells. Science 349 (2015), 1228–1232.
19. Broz, P., Von Moltke, J., Jones, J.W., Vance, R.E., Monack, D.M., Differential requirement for caspase-1 autoproteolysis in pathogen-induced cell death and cytokine processing. Cell Host Microbe 8 (2010), 471–483.
20. Brunette, R.L., et al. Extensive evolutionary and functional diversity among mammalian AIM2-like receptors. J. Exp. Med. 209 (2012), 1969–1983.
21. Burdette, D.L., Vance, R.E., STING and the innate immune response to nucleic acids in the cytosol. Nat. Immunol. 14 (2013), 19–26.
22. Cai, X., Chiu, Y.H., Chen, Z.J., The cGAS-cGAMP-STING pathway of cytosolic DNA sensing and signaling. Mol. Cell 54 (2014), 289–296.
23. Chae, J.J., Wood, G., Richard, K., Jaffe, H., Colburn, N.T., Masters, S.L., Gumucio, D.L., Shoham, N.G., Kastner, D.L., The familial Mediterranean fever protein, pyrin, is cleaved by caspase-1 and activates NF-kB through its N-terminal fragment. Blood 12 (2008), 6–7.
24. Chang, T.H., Liao, C.L., Lin, Y.L., Flavivirus induces interferon-beta gene expression through a pathway involving RIG-I-dependent IRF-3 and PI3K-dependent NF-κB activation. Microbes Infect. 8 (2006), 157–171.
25. Chelbi-Alix, M.K., Quignon, F., Pelicano, L., Koken, M.H., de Thé H., Resistance to virus infection conferred by the interferon-induced promyelocytic leukemia protein. J. Virol. 72 (1998), 1043–1051.
26. Chen, M., et al. TRIM14 inhibits cGAS degradation mediated by selective autophagy receptor p62 to promote innate immune responses. Mol. Cell 64 (2016), 105–119.
27. Chiu, Y.-H., MacMillan, J.B., Chen, Z.J., RNA polymerase III detects cytosolic DNA and induces type-I interferons through the RIG-I pathway. Cell 138 (2009), 576–591.
28. Choi, U.Y., Kang, J.S., Hwang, Y.S., Kim, Y.J., Oligoadenylate synthase-like (OASL) proteins: dual functions and associations with diseases. Exp. Mol. Med., 47, 2015, e144.
29. Compton, T., et al. Human cytomegalovirus activates inflammatory cytokine responses via CD14 and toll-like receptor 2. J. Virol. 77 (2003), 4588–4596.
30. Cridland, J.A., et al. The mammalian PYHIN gene family: phylogeny, evolution and expression. BMC Evol. Biol., 12, 2012, 140.
31. Dambuza, I.M., Brown, G.D., C-type lectins in immunity: recent developments. Curr. Opin. Immunol. 32 (2015), 21–27.
32. de Witte, L., Abt, M., Schneider-Schaulies, S., van Kooyk, Y., Geijtenbeek, T.B.H., Measles virus targets DC-SIGN to enhance dendritic cell infection. J. Virol. 80 (2006), 3477–3486.
33. Diebold, S.S., Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 303 (2004), 1529–1531.
34. Di Pietro, A., et al. TRIM22 inhibits influenza A virus infection by targeting the viral nucleoprotein for degradation. J. Virol. 87 (2013), 4523–4533.
35. Dixit, E., Kagan, J.C., Intracellular pathogen detection by RIG-I-like receptors. Adv. Immunol. 117 (2013), 99–125.
36. Drummond, R.A., Brown, G.D., Signalling C-type lectins in antimicrobial immunity. PLoS Pathog. 9 (2013), 9–11.
37. Duewell, P., et al. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature 464 (2010), 1357–1361.
38. Dutrieux, J., et al. PML/TRIM19-dependent inhibition of retroviral reverse-transcription by Daxx. PLoS Pathog. 11 (2015), 1–22.
39. Eichholz, K., et al. Immune-complexed adenovirus induce AIM2-mediated pyroptosis in human dendritic cells. PLoS Pathog., 12, 2016, e1005871.
40. El Asmi, F., et al. Implication of PMLIV in both intrinsic and innate immunity. PLoS Pathog., 10(2), 2014, e1003975, 10.1371/journal.ppat.1003975.
41. Errett, J.S., Suthar, M.S., McMillan, A., Diamond, M.S., Gale, M., The essential, nonredundant roles of RIG-I and MDA5 in detecting and controlling west nile virus infection. J. Virol. 87 (2013), 11416–11425.
42. Espinosa, A., et al. Loss of the lupus autoantigen Ro52/Trim21 induces tissue inflammation and systemic autoimmunity by disregulating the IL-23-Th17 pathway. J. Exp. Med. 206 (2009), 1661–1671.
43. Fan, W., et al. Swine TRIM21 restricts FMDV infection via an intracellular neutralization mechanism. Antiviral Res. 127 (2016), 32–40.
44. Fan, W., et al. TRIM52 inhibits Japanese encephalitis virus replication by degrading the viral NS2A. Sci. Rep., 6, 2016, 33698.
45. Fan, W., et al. TRIM52: a nuclear TRIM protein that positively regulates the nuclear factor-kappa B signaling pathway. Mol. Immunol. 82 (2017), 114–122.
46. Farhat, K., et al. Heterodimerization of TLR2 with TLR1 or TLR6 expands the ligand spectrum but does not lead to differential signaling. J. Leukoc. Biol. 83 (2007), 692–701.
47. Ferguson, W., Dvora, S., Gallo, J., Orth, A., Boissinot, S., Long-term balancing selection at the West Nile virus resistance gene, Oas1b, maintains transspecific polymorphisms in the house mouse. Mol. Biol. Evol. 25 (2008), 1609–1618.
48. Fernandes-Alnemri, T., et al. AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA. Nature 458 (2009), 509–513.
49. Ferri, F., et al. TRIM33 switches off Ifnb1 gene transcription during the late phase of macrophage activation. Nat. Commun., 6, 2015, 8900.
50. Figueiredo, A., Hope, T.J., KAPs off for HIV-1 integration. Cell Host Microbe 9 (2011), 447–448.
51. Fiola, S., Gosselin, D., Takada, K., Gosselin, J., TLR9 contributes to the recognition of EBV by primary monocytes and plasmacytoid dendritic cells. J. Immunol. 185 (2010), 3620–3631.
52. Fitzgerald, K.A., et al. IKKɛ and TBK1 are essential components of the IRF3 signaling pathway. Nat. Immunol. 4 (2003), 491–496.
53. Fletcher, A.J., James, L.C., Coordinated neutralization and immune activation by the cytosolic antibody receptor TRIM21. J. Virol. 90 (2016), 4856–4859.
54. Fletcher, A.J., Mallery, D.L., Watkinson, R.E., Dickson, C.F., James, L.C., Sequential ubiquitination and deubiquitination enzymes synchronise the dual sensor and effector functions of TRIM21. Proc. Natl. Acad. Sci. U.S.A. 112 (2014), 10014–10019.
55. Fletcher, A.J., et al. TRIM5α requires Ube2W to anchor Lys63-linked ubiquitin chains and restrict reverse transcription. EMBO J. 34 (2015), 1–18.
56. Franchi, L., et al. Intracellular NOD-like receptors in innate immunity, infection and disease. Cell. Microbiol. 10 (2008), 1–8.
57. Franchi, L., Warner, N., Viani, K., Nuñez, G., Function of Nod-like receptors in microbial recognition and host defense. Immunol. Rev. 227 (2009), 106–128.
58. Fu, B., et al. TRIM32 senses and restricts influenza A virus by ubiquitination of PB1 polymerase. PLoS Pathog. 11 (2015), 1–23.
59. Fujimoto, M., et al. Prevalence and clinical relevance of 52-kDa and 60-kDa Ro/SS-A autoantibodies in Japanese patients with systemic sclerosis. Ann. Rheum. Dis. 56 (1997), 667–670.
60. Furr, S.R., Moerdyk-Schauwecker, M., Grdzelishvili, V.Z., Marriott, I., RIG-I mediates nonsegmented negative-sense RNA virus-induced inflammatory immune responses of primary human astrocytes. Glia 58 (2010), 1620–1629.
61. Gack, M.U., Mechanisms of RIG-I-like receptor activation and manipulation by viral pathogens. J. Virol. 88 (2014), 5213–5216.
62. Gack, M.U., et al. TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity. Nature 446 (2007), 916–920.
63. Gallouet, A.-S., et al. Macrophage production and activation are dependent on TRIM33. Oncotarget 8 (2017), 5111–5122.
64. Ganser-Pornillos, B.K., et al. Hexagonal assembly of a restricting TRIM5 protein. Proc. Natl. Acad. Sci. U.S.A. 108 (2011), 534–539.
65. Gao, D., et al. Cyclic GMP-AMP synthase is an innate immune sensor of HIV and other retroviruses. Science 341 (2014), 903–906.
66. Geijtenbeek, T.B.H., Gringhuis, S.I., Signalling through C-type lectin receptors: shaping immune responses. Nat. Rev. Immunol. 9 (2009), 465–479.
67. Geijtenbeek, T.B., et al. DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell 100 (2000), 587–597.
68. Gitlin, L., et al. Essential role of mda-5 in type I IFN responses to polyriboinosinic:polyribocytidylic acid and encephalomyocarditis picornavirus. Proc. Natl. Acad. Sci. U.S.A. 103 (2006), 8459–8464.
69. Gough, D.J., Messina, N.L., Clarke, C.J.P., Johnstone, R.W., Levy, D.E., Constitutive type I interferon modulates homeostatic balance through tonic signaling. Immunity 36 (2012), 759–785.
70. Gray, E.E., et al. The AIM2-like receptors are dispensable for the interferon response to intracellular DNA. Immunity 45 (2016), 255–266.
71. Grütter, M.G., Luban, J., TRIM5 structure, HIV-1 capsid recognition, and innate immune signaling. Curr. Opin. Virol. 2 (2012), 142–150.
72. Guo, H., Callaway, J.B., Ting, J.P.-Y., Inflammasomes: mechanism of action, role in disease and therapeutics. Nat. Med. 21 (2015), 677–687.
73. Han, K., Lou, D.I., Sawyer, S.L., Identification of a genomic reservoir for new trim genes in primate genomes. PLoS Genet., 7(12), 2011, e1002388.
74. Hashimoto, M., et al. Lipoprotein is a predominant toll-like receptor 2 ligand in staphylococcus aureus cell wall components. Int. Immunol. 18 (2006), 355–362.
75. Hauler, F., Mallery, D.L., McEwan, W.A., Bidgood, S.R., James, L.C., AAA ATPase p97/VCP is essential for TRIM21-mediated virus neutralization. Proc. Natl. Acad. Sci. U.S.A. 109 (2012), 19733–19738.
76. Hayashi, F., et al. The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature 410 (2001), 1099–1103.
77. Heid, M.E., et al. Mitochondrial reactive oxygen species induces NLRP3-dependent lysosomal damage and inflammasome activation. J. Immunol. 191 (2013), 5230–5238.
78. Hemmi, H., et al. A toll-like receptor recognizes bacterial DNA. Nature 408 (2000), 740–745.
79. Higgs, R., Gabhann, J.N., Larbi, N.B., Breen, E.P., Fitzgerald, K.A., Jefferies, C.A., The E3 ubiquitin ligase Ro52 negatively regulates IFN-β production post-pathogen recognition by polyubiquitin-madiated degradation of IRF3. J. Immunol. 181 (2008), 1780–1786.
80. Higgs, R., et al. Self protection from anti-viral responses—Ro52 promotes degradation of the transcription factor IRF7 downstream of the viral toll-like receptors. PLoS One 5 (2010), 1–7.
81. Hornung, V., Latz, E., Critical functions of priming and lysosomal damage for NLRP3 activation. Eur. J. Immunol. 6 (2010), 620–623.
82. Hornung, V., et al. AIM2 recognizes cytosolic dsDNA and forms a caspase-1 activating inflammasome with ASC. Nature 458 (2009), 514–518.
83. Hornung, V., Hartmann, R., Ablasser, A., Hopfner, K.-P., OAS proteins and cGAS: unifying concepts in sensing and responding to cytosolic nucleic acids. Nat. Rev. Immunol., 14(8), 2014, 521.
84. Hoving, J.C., Wilson, G.J., Brown, G.D., Signalling C-type lectin receptors, microbial recognition and immunity. Cell. Microbiol. 16 (2014), 185–194.
85. Hu, M.-M., Shu, H.-B., Multifaceted roles of TRIM38 in innate immune and inflammatory responses. Cell. Mol. Immunol. 14 (2017), 331–338.
86. Hu, Y., et al. Tripartite-motif protein 30 negatively regulates NLRP3 inflammasome activation by modulating reactive oxygen species production. J. Immunol. 185 (2010), 7699–7705.
87. Hu, M.-M., et al. TRIM38 inhibits TNFα- and IL-1β-triggered NF-κB activation by mediating lysosome-dependent degradation of TAB2/3. Proc. Natl. Acad. Sci. U.S.A. 111 (2014), 1509–1514.
88. Hu, M.-M., et al. TRIM38 negatively regulates TLR3/4-mediated innate immune and inflammatory responses by two sequential and distinct mechanisms. J. Immunol. 195 (2015), 4415–4425.
89. Hu, M.M., et al. Sumoylation promotes the stability of the DNA sensor cGAS and the adaptor STING to regulate the kinetics of response to DNA virus. Immunity 45 (2016), 555–569.
90. Huang, B., Baek, S., Trim13 potentiates toll-like receptor 2-mediated nuclear factor κB activation via K29-linked polyubiquitination of tumor necrosis factor receptor-associated factor 6. Mol. Pharmacol. 91 (2017), 307–316.
91. Huang, Y., et al. Fish TRIM8 exerts antiviral roles through regulation of the proinflammatory factors and interferon signaling. Fish Shellfish Immunol. 54 (2016), 435–444.
92. Huang, Y., et al. Grouper TRIM13 exerts negative regulation of antiviral immune response against nodavirus. Fish Shellfish Immunol. 55 (2016), 106–115.
93. Ichinohe, T., Lee, H.K., Ogura, Y., Flavell, R., Iwasaki, A., Inflammasome recognition of influenza virus is essential for adaptive immune responses. J. Exp. Med. 206 (2009), 79–87.
94. Ichinohe, T., Pang, I.K., Iwasaki, A., Influenza virus activates inflammasomes via its intracellular M2 ion channel. Nat. Immunol. 11 (2010), 404–410.
95. Iqbal, K., Liu, F., Gong, C.-X., Tau and neurodegenerative disease: the story so far. Nat. Rev. Neurol. 12 (2015), 15–27.
96. Ireton, R.C., Gale, M., RIG-I like receptors in antiviral immunity and therapeutic applications. Virus 3 (2011), 906–919.
97. James, L.C., Keeble, A.H., Khan, Z., Rhodes, D.a., Trowsdale, J., Structural basis for PRYSPRY-mediated tripartite motif (TRIM) protein function. Proc. Natl. Acad. Sci. U.S.A. 104 (2007), 6200–6205.
98. Jia, X., et al. The ubiquitin ligase RNF125 targets innate immune adaptor protein TRIM14 for ubiquitination and degradation. J. Immunol., 198, 2017, 1601322, 10.4049/jimmunol.1601322.
99. Jiang, X., et al. Ubiquitin-induced oligomerization of the RNA sensors RIG-I and MDA5 activates antiviral innate immune response. Immunity 36 (2012), 959–973.
100. Jiang, S., Li, X., Hess, N.J., Guan, Y., Tapping, R.I., TLR10 is a negative regulator of both MyD88-dependent and -independent TLR signaling. J. Immunol. 196 (2016), 3834–3841.
101. Jønsson, K.L., et al. IFI16 is required for DNA sensing in human macrophages by promoting production and function of cGAMP. Nat. Commun., 8, 2017, 14391.
102. Kagan, J.C., Barton, G.M., Transduction by pattern-recognition receptors, Cold Spring Harb. Perspect. Biol., 2014, 1–16.
103. Kagan, J.C., Barton, G.M., Emerging principles governing signal transduction by pattern-recognition receptors. Cold Spring Harb. Perspect. Biol. 33 (2016), 395–401.
104. Kahle, T., et al. TRIM19/PML restricts HIV infection in a cell type-dependent manner. Virus 8 (2016), 1–18.
105. Kajaste-Rudnitski, A., et al. TRIM22 inhibits HIV-1 transcription independently of its E3 ubiquitin ligase activity, tat, and NF-κB-responsive long terminal repeat elements. J. Virol. 85 (2011), 5183–5196.
106. Kane, M., et al. Identification of interferon-stimulated genes with antiretroviral activity. Cell Host Microbe 20 (2016), 392–405.
107. Kang, J.Y., et al. Recognition of lipopeptide patterns by toll-like receptor 2-toll-like receptor 6 heterodimer. Immunity 31 (2009), 873–884.
108. Kanneganti, T.-D., Central roles of NLRs and inflammasomes in viral infection. Nat. Rev. Immunol. 10 (2010), 688–698.
109. Kawai, T., Akira, S., The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat. Immunol. 11 (2010), 373–384.
110. Kawasaki, T., Kawai, T., Toll-like receptor signaling pathways. Front. Immunol. 5 (2014), 1–8.
111. Kayagaki, N., et al. Noncanonical inflammasome activation by intracellular lps independent of tlr4. Science 130 (2013), 1246–1249.
112. Keeble, A.H., Khan, Z., Forster, A., James, L.C., TRIM21 is an IgG receptor that is structurally, thermodynamically, and kinetically conserved. Proc. Natl. Acad. Sci. U.S.A. 105 (2008), 6045–6050.
113. Kell, A.M., Gale, M. Jr., RIG-I in RNA virus recognition. Virology 479–480 (2015), 110–121, 10.1016/j.virol.2015.02.017.RIG-I.
114. Kim, Y.K., Shin, J.S., Nahm, M.H., NOD-like receptors in infection, immunity, and diseases. Yonsei Med. J. 57 (2016), 5–14.
115. Klasse, P.J., Review article neutralization of virus infectivity by antibodies: old problems in new perspectives. Adv. Biol., 2014, 2014 pii: 157895.
116. Koliopoulos, M.G., Esposito, D., Christodoulou, E., Taylor, I.A., Rittinger, K., Functional role of TRIM E 3 ligase oligomerization and regulation of catalytic activity. EMBO J. 35 (2016), 1–15.
117. Kondo, T., Watanabe, M., Hatakeyama, S., TRIM59 interacts with ECSIT and negatively regulates NF-κB and IRF-3/7-mediated signal pathways. Biochem. Biophys. Res. Commun. 422 (2012), 501–507.
118. Kong, H.J., et al. Cutting edge: autoantigen Ro52 is an interferon inducible E3 ligase that ubiquitinates IRF-8 and enhances cytokine expression in macrophages. J. Immunol. 179 (2007), 26–30.
119. Koshiba, T., Mitochondrial-mediated antiviral immunity. Biochim. Biophys. Acta 1833 (2013), 225–232.
120. Kowalinski, E., et al. Structural basis for the activation of innate immune pattern-recognition receptor RIG-I by viral RNA. Cell 147 (2011), 423–435.
121. Kranzusch, P.J., Lee, A.S., Berger, J.M., Jennifer, A., Structure of human cGAS reveals a conserved family of second-messenger enzymes in innate immunity. Cell Rep. 3 (2013), 1362–1368.
122. Krug, A., et al. TLR9-dependent recognition of MCMV by IPC and DC generates coordinated cytokine responses that activate antiviral NK cell function. Immunity 21 (2004), 107–119.
123. Kutluay, S.B., Perez-Caballero, D., Bieniasz, P.D., Fates of retroviral core components during unrestricted and TRIM5-restricted infection. PLoS Pathog., 9(3), 2013, e1003214, 10.1371/journal.ppat.1003214.
124. Kwon, Y.-C., Kang, J.-I., Hwang, S.B., Ahn, B.-Y., The ribonuclease L-dependent antiviral roles of human 2’,5’-oligoadenylate synthetase family members against hepatitis C virus. FEBS Lett. 587 (2013), 156–164.
125. Lam, E., Stein, S., Falck-Pedersen, E., Adenovirus detection by the cGAS/STING/TBK1 DNA sensing cascade. J. Virol. 88 (2014), 974–981.
126. Lamkanfi, M., Dixit, V.M., Review mechanisms and functions of inflammasomes. Cell 157 (2014), 1013–1022.
127. Lang, X., et al. TRIM65-catalized ubiquitination is essential for MDA5-mediated antiviral innate immunity. J. Exp. Med. 214 (2016), 459–473, 10.1084/jem.20160592.
128. Latsoudis, H., et al. Differential expression of miR-4520a associated with pyrin mutations in familial mediterranean fever (FMF). J. Cell. Physiol. 232 (2017), 1326–1336.
129. Latz, E., Xiao, T.S., Stutz, A., Activation and regulation of the inflammasomes. Nat. Rev. Immunol. 13 (2013), 397–411.
130. Laurent-Rolle, M., et al. The interferon signaling antagonist function of yellow fever virus NS5 protein is activated by type I interferon. Cell Host Microbe 16 (2014), 314–327.
131. Lawrence, T.M., Hudacek, A.W., de Zoete, M.R., Flavell, R.A., Schnell, M.J., Rabies virus is recognized by the NLRP3 inflammasome and activates interleukin-1 release in murine dendritic cells. J. Virol. 87 (2013), 5848–5857.
132. Lazear, H.M., Diamond, M.S., New insights into innate immune restriction of west nile virus infection. Curr. Opin. Virol. 1848 (2016), 3047–3054.
133. Lazzari, E., et al. TRIpartite motif 21 (TRIM21) differentially regulates the stability of interferon regulatory factor 5 (IRF5) isoforms. PLoS One 9 (2014), 1–10.
134. Lee, Y., Song, B., Park, C., Kwon, K.S., TRIM11 negatively regulates IFNβ production and antiviral activity by targeting TBK1. PLoS One 8 (2013), 1–12.
135. Lee, S.M.Y., et al. Toll-like receptor 10 is involved in induction of innate immune responses to influenza virus infection. Proc. Natl. Acad. Sci. U.S.A. 111 (2014), 3793–3798.
136. Lee, J., et al. TNF-α induced by hepatitis C virus via TLR7 and TLR8 in hepatocytes supports interferon signaling via an autocrine mechanism. PLoS Pathog. 11 (2015), 1–19.
137. Lester, S.N., Li, K., Toll-like receptors in antiviral innate immunity. J. Mol. Biol. 426 (2014), 1246–1264.
138. Li, J., et al. DDX19A senses viral RNA and mediates NLRP3-dependent inflammasome activation. J. Immunol. 195 (2015), 5732–5749.
139. Li, Y.L., et al. Primate TRIM5 proteins form hexagonal nets on HIV-1 capsids. eLife 5 (2016), 1–33.
140. Li, M.M.H., et al. TRIM25 enhances the antiviral action of zinc-finger antiviral protein (ZAP). PLoS Pathog. 13 (2017), 1–25.
141. Liang, Q., et al. Tripartite motif-containing protein 28 is a small ubiquitin-related modifier E3 ligase and negative regulator of IFN regulatory factor 7. J. Immunol. 187 (2011), 4754–4763.
142. Lin, R.J., et al. Distinct antiviral roles for human 2’,5’-oligoadenylate synthetase family members against dengue virus infection. J. Immunol. 183 (2009), 8035–8043.
143. Liu, B., et al. Overlapping and distinct molecular determinants dictating the antiviral activities of TRIM56 against flaviviruses and coronavirus. J. Virol. 88 (2014), 13821–13835.
144. Liu, T., et al. TRIM11 suppresses AIM2 inflammasome by degrading AIM2 via p62-dependent selective autophagy. Cell Rep. 16 (2016), 1988–2002.
145. Liu, B., et al. The C-terminal tail of TRIM56 dictates antiviral restriction of influenza A and B viruses by impeding viral RNA synthesis. J. Virol. 90 (2016), 4369–4382.
146. Liu, Y., Olagnier, D., Lin, R., Host and viral modulation of RIG-I-mediated antiviral immunity. Front. Immunol. 7 (2017), 1–12.
147. Liu, B., et al. The ubiquitin E3 ligase TRIM31 promotes aggregation and activation of the signaling adaptor MAVS through Lys63-linked polyubiquitination. Nat. Immunol. 18 (2017), 214–224.
148. Loo, Y.-M., et al. Distinct RIG-I and MDA5 signaling by RNA viruses in innate immunity. J. Virol. 82 (2008), 335–345.
149. Lu, Y.C., Yeh, W.C., Ohashi, P.S., LPS/TLR4 signal transduction pathway. Cytokine 42 (2008), 145–151.
150. Luisoni, S., et al. Co-option of membrane wounding enables virus penetration into cells. Cell Host Microbe 18 (2015), 75–85.
151. Lukic, Z., et al. TRIM5α associates with proteasomal subunits in cells while in complex with HIV-1 virions. Retrovirology, 8, 2011, 93.
152. Lund, J.M., et al. Recognition of single-stranded RNA viruses by Toll-like receptor 7. Proc. Natl. Acad. Sci. U.S.A. 101 (2004), 5598–5603.
153. Lusic, M., et al. Proximity to PML nuclear bodies regulates HIV-1 latency in CD4 + T cells. Cell Host Microbe 13 (2013), 665–677.
154. Maharaj, N.P., Wies, E., Stoll, A., Gack, M.U., Conventional protein kinase C-α (PKC-α) and PKC-β negatively regulate RIG-I antiviral signal transduction. J. Virol. 86 (2012), 1358–1371.
155. Mäkelä S.M., et al. RIG-I signaling is essential for influenza B virus-induced rapid interferon gene expression. J. Virol. 89 (2015), 12014–12025.
156. Malathi, K., Dong, B., Gale, M.J., Silverman, R.H., Small self-RNA generated by RNase L amplifies antiviral innate immunity. Nature 448 (2007), 816–819.
157. Mallery, D.L., et al. Antibodies mediate intracellular immunity through tripartite motif-containing 21 (TRIM21). Proc. Natl. Acad. Sci. U.S.A. 107 (2010), 19985–19990.
158. Manukyan, G., Aminov, R., Update on pyrin functions and mechanisms of familial mediterranean fever. Front. Microbiol. 7 (2016), 1–8.
159. Marín, I., Origin and diversification of TRIM ubiquitin ligases. PLoS One, 7(11), 2012, e50030, 10.1371/journal.pone.0050030.
160. Masroori, N., Merindol, N., Berthoux, L., The interferon-induced antiviral protein PML (TRIM19) promotes the restriction and transcriptional silencing of lentiviruses in a context-specific, isoform-specific fashion. Retrovirology, 13, 2016, 19.
161. Masters, S.L., et al. Familial autoinflammation with neutrophilic dermatosis reveals a regulatory mechanism of pyrin activation. Sci. Transl. Med., 8, 2016, 332ra45.
162. McCartney, S.A., et al. MDA-5 recognition of a murine norovirus. PLoS Pathog. 4 (2008), 1–7.
163. McEwan, W.A., et al. Regulation of virus neutralization and the persistent fraction by TRIM21. J. Virol. 86 (2012), 8482–8491.
164. McEwan, W.A., et al. Intracellular antibody-bound pathogens stimulate immune signaling via the Fc receptor TRIM21. Nat. Immunol. 14 (2013), 327–336.
165. McEwan, W.A., et al. Cytosolic Fc receptor TRIM21 inhibits seeded tau aggregation. Proc. Natl. Acad. Sci. U.S.A., 114, 2017, 201607215.
166. Metzger, M.B., Hristova, V.A., Weissman, A.M., HECT and RING finger families of E3 ubiquitin ligases at a glance. J. Cell Sci. 125 (2012), 531–537.
167. Minamitani, T., Iwakiri, D., Takada, K., Adenovirus virus-associated RNAs induce type I interferon expression through a RIG-I-mediated pathway. J. Virol. 85 (2011), 4035–4040.
168. Mitchell, A.M., Hirsch, M.L., Li, C., Samulski, R.J., Promyelocytic leukemia protein is a cell-intrinsic factor inhibiting parvovirus DNA replication. J. Virol. 88 (2014), 925–936.
169. Mitoma, H., et al. The DHX33 RNA helicase senses cytosolic RNA and activates the NLRP3 inflammasome. Immunity 39 (2013), 123–135.
170. Monteith, A.J., et al. Defects in lysosomal maturation facilitate the activation of innate sensors in systemic lupus erythematosus. Proc. Natl. Acad. Sci. U.S.A. 113 (2016), E2142–E2151.
171. Moore, C.B., et al. NLRX1 is a regulator of mitochondrial antiviral immunity. Nature 451 (2008), 573–577.
172. Muñoz-Planillo, R., Kuffa, P., Giovanny Martínez-Colón, B.L.S., Rajendiran, T.M., Núñez, G., K + efflux is the common trigger of NLRP3 inflammasome activation by bacterial toxins and particulate matter. Immunity 38 (2013), 1142–1153.
173. Murawski, M.R., et al. Respiratory syncytial virus activates innate immunity through Toll-like receptor 2. J. Virol. 83 (2009), 1492–1500.
174. Narayan, K., et al. TRIM13 is a negative regulator of MDA5-mediated type I interferon production. J. Virol. 88 (2014), 10748–10757.
175. Nenasheva, V.V., et al. Enhanced expression of trim14 gene suppressed Sindbis virus reproduction and modulated the transcription of a large number of genes of innate immunity. Immunol. Res. 62 (2015), 255–262.
176. Nisole, S., Stoye, J.P., Saïb, A., TRIM family proteins: retroviral restriction and antiviral defence. Nat. Rev. Microbiol. 3 (2005), 799–808.
177. Noguchi, K., et al. Trim40 promotes neddylation of IKKy and is downregulated in gastrointestinal cancers. Carcinogenesis 32 (2011), 995–1004.
178. Odendall, C., Kagan, J.C., Activation and pathogenic manipulation of the sensors of the innate immune system. Microbes Infect. 19 (2017), 229–237, 10.1016/j.micinf.2017.01.003.
179. Oke, V., Wahren-Herlenius, M., The immunobiology of Ro52 (TRIM21) in autoimmunity: a critical review. J. Autoimmun. 39 (2012), 77–82.
180. Okumura, F., Matsunaga, Y., Katayama, Y., Nakayama, K.I., Hatakeyama, S., TRIM8 modulates STAT3 activity through negative regulation of PIAS3. J. Cell Sci. 123 (2010), 2238–2245.
181. Oliveira-Nascimento, L., Massari, P., Wetzler, L.M., The role of TLR2 in infection and immunity. Front. Immunol. 3 (2012), 1–17.
182. Oosting, M., et al. Human TLR10 is an anti-inflammatory pattern-recognition receptor. Proc. Natl. Acad. Sci. U.S.A. 111 (2014), E4478–E4484.
183. Osorio, F., Reis e Sousa, C., Myeloid C-type lectin receptors in pathogen recognition and host defense. Immunity 34 (2011), 651–664.
184. Ozato, K., Shin, D.-M., Chang, T.-H., Morse, H.C., TRIM family proteins and their emerging roles in innate immunity. Nat. Rev. Immunol. 8 (2008), 849–860.
185. Ozato, K., Shin, D., Chang, T., Morse, H., TRIM family proteins and their emerging roles in innate immunity. Nat. Rev. Immunol. 8 (2012), 849–860.
186. Paijo, J., et al. cGAS senses human cytomegalovirus and induces type I interferon responses in human monocyte-derived cells. PLoS Pathog. 12 (2016), 1–24.
187. Papon, L., et al. The viral RNA recognition sensor RIG-I is degraded during encephalomyocarditis virus (EMCV) infection. Virology 393 (2009), 311–318.
188. Park, Y.H., Wood, G., Kastner, D.L., Chae, J.J., Pyrin inflammasome activation and RhoA signaling in the autoinflammatory diseases FMF and HIDS. Nat. Immunol. 17 (2016), 914–921.
189. Parvatiyar, K., Cheng, G., NOD so fast: NLRX1 puts the brake on inflammation. Immunity 34 (2011), 821–822.
190. Peisley, A., Wu, B., Yao, H., Walz, T., Hur, S., RIG-I forms signaling-competent filaments in an ATP-dependent, ubiquitin-independent manner. Mol. Cell 51 (2013), 573–583.
191. Peisley, A., Wu, B., Xu, H., Chen, Z.J., Hur, S., Structural basis for ubiquitin-mediated antiviral signal activation by RIG-I. Nature 509 (2014), 110–114.
192. Pertel, T., et al. TRIM5 is an innate immune sensor for the retrovirus capsid lattice. Nature 472 (2011), 361–365.
193. Perwitasari, O., Cho, H., Diamond, M.S., Gale, M., Inhibitor of kB kinase ɛ (IKKɛ), STAT1, and IFIT2 proteins define novel innate immune effector pathway against West Nile virus infection. J. Biol. Chem. 286 (2011), 44412–44423.
194. Poole, E., et al. Identification of TRIM23 as a cofactor involved in the regulation of NF-kB by human cytomegalovirus. J. Virol. 83 (2009), 3581–3590.
195. Qin, Y., et al. TRIM9 short isoform preferentially promotes DNA and RNA virus-induced production of type I interferon by recruiting GSK3β to TBK1. Cell Res. 26 (2016), 613–628.
196. Rajan, J.V., Warren, S.E., Miao1, E.A., Aderem, A., Activation of the NLRP3 inflammasome by intracellular poly I:C. FEBS Lett. 584 (2010), 4627–4632.
197. Rajan, J.V., Rodriguez, D., Miao, E.A., Aderem, A., The NLRP3 inflammasome detects encephalomyocarditis virus and vesicular stomatitis virus infection. J. Virol. 85 (2011), 4167–4172.
198. Rajsbaum, R., Versteeg, G.A., Schmid, S., Maestre, A.M., Belicha-Villanueva, A., Martínez-Romero, C., Patel, J.R., Morrison, J., Pisanelli, G., Miorin, L., Laurent-Rolle, M., Moulton, H.M., Stein, D.A., Fernandez-Ses, A., Sastre, A.G., Unanchored K48-linked poly-ubiquitin synthesized by the E3-ubiquitin ligase TRIM6 stimulates the interferon-IKKɛ kinase mediated antiviral response. Immunity 40 (2014), 880–895.
199. Rallabhandi, P., et al. Respiratory syncytial virus fusion protein-induced toll-like receptor 4 (TLR4) signaling is inhibited by the TLR4 antagonists Rhodobacter sphaeroides lipopolysaccharide and eritoran (E5564) and requires direct interaction with MD-2. mBio, 3(4), 2012, e00218-12, 10.1128/mBio.00218-127.
200. Ran, Y., et al. Autoubiquitination of TRIM 26 links TBK 1 to NEMO in RLR-mediated innate antiviral immune response. J. Mol. Cell Biol. 8 (2016), 31–43.
201. Rasmussen, S.B., et al. Herpes simplex virus infection is sensed by both toll-like receptors and RIG-like receptors, which synergize to induce type I interferon production. J. Gen. Virol. 90 (2009), 74–78.
202. Rathinam, V.A.K., et al. The AIM2 inflammasome is essential for host defense against cytosolic bacteria and DNA viruses. Nat. Immunol. 11 (2010), 395–402.
203. Ratsimandresy, R.A., Dorfleutner, A., Stehlik, C., An update on PYRIN domain-containing pattern recognition receptors: from immunity to pathology. Front. Immunol. 4 (2013), 1–20.
204. Rehwinkel, J., et al. RIG-I detects viral genomic RNA during negative-strand RNA virus infection. Cell 140 (2010), 397–408.
205. Reinert, L.S., et al. Sensing of HSV-1 by the cGAS-STING pathway in microglia orchestrates antiviral defence in the CNS. Nat. Commun., 7, 2016, 13348.
206. Richards, N., et al. Interaction between pyrin and the apoptotic speck protein (ASC) modulates ASC-induced apoptosis. J. Biol. Chem. 276 (2001), 39320–39329.
207. Roa, A., et al. RING domain mutations uncouple TRIM5 restriction of HIV-1 from inhibition of reverse transcription and acceleration of uncoating. J. Virol. 86 (2012), 1717–1727.
208. Rogozin, I.B., Aravind, L., Koonin, E.V., Differential action of natural selection on the N and C-terminal domains of 2′-5′ oligoadenylate synthetases and the potential nuclease function of the C-terminal domain. J. Mol. Biol. 326 (2003), 1449–1461.
209. Rold, C.J., Aiken, C., Proteasomal degradation of TRIM5α during retrovirus restriction. PLoS Pathog., 4(5), 2008, e1000074, 10.1371/journal.ppat.1000074.
210. Roopenian, D.C., Akilesh, S., FcRn: the neonatal Fc receptor comes of age. Nat. Rev. Immunol. 7 (2007), 715–725.
211. Sabbah, A., et al. Activation of innate immune antiviral responses by Nod2. Nat. Immunol. 10 (2009), 1073–1080.
212. Saito, T., Owen, D.M., Jiang, F., Marcotrigiano, J., Gale, M. Jr., Innate immunity induced by composition-dependent RIG-I recognition of hepatitis C virus RNA. Nature 454 (2008), 523–527.
213. Saitoh, T., et al. Negative regulation of interferon-regulatory factor 3-dependent innate antiviral response by the prolyl isomerase Pin1. Nat. Immunol. 7 (2006), 598–605.
214. Sanchez, J.G., et al. Mechanism of TRIM25 catalytic activation in the antiviral RIG-I pathway. Cell Rep. 16 (2016), 1315–1325.
215. Sancho, D., Reis e Sousa, C., Signaling by myeloid C-type lectin receptors in immunity and homeostasis. Annu. Rev. Immunol. 30 (2012), 491–529.
216. Sayah, D.M., Sokolskaja, E., Berthoux, L., Luban, J., Cyclophilin A retrotransposition into TRIM5 explains owl monkey resistance to HIV-1. Nature 430 (2004), 569–573.
217. Schenk, M., Belisle, J.T., Modlin, R.L., TLR2 looks at lipoproteins. Immunity 31 (2009), 847–849.
218. Schilling, E.-M., Scherer, M., Reuter, N., Schweininger, J., Muller, Y.A., Stamminger, T., The human cytomegalovirus IE1 protein antagonizes PML nuclear body-mediated intrinsic immunity via the inhibition of PML de novo SUMOylation. J. Virol. 91 (2017), 1–17.
219. Schlee, M., Master sensors of pathogenic RNA-RIG-I like receptors. Immunobiology 218 (2013), 1322–1335.
220. Schoggins, J.W., et al. Pan-viral specificity of IFN-induced genes reveals new roles for cGAS in innate immunity. Nature 505 (2014), 691–695.
221. Shen, Y., et al. TRIM56 is an essential component of the TLR3 antiviral signaling pathway. J. Biol. Chem. 287 (2012), 36404–36413.
222. Shi, M., et al. TRIM30α negatively regulates TLR-mediated NF-κB activation by targeting TAB2 and TAB3 for degradation. Nat. Immunol. 9 (2008), 369–377.
223. Shibata, M., Sato, T., Nukiwa, R., Ariga, T., Hatakeyama, S., TRIM45 negatively regulates NF-kB-mediated transcription and suppresses cell proliferation. Biochem. Biophys. Res. Commun. 423 (2012), 104–109.
224. Shimizu, A., et al. Characterisation of cytoplasmic DNA complementary to non-retroviral RNA viruses in human cells. Sci. Rep. 4 (2014), 1–9.
225. Singh, R., et al. Association of TRIM22 with the type 1 interferon response and viral control during primary HIV-1 infection. J. Virol. 85 (2011), 208–216.
226. Song, H., et al. The E3 ubiquitin ligase TRIM31 attenuates NLRP3 inflammasome activation by promoting proteasomal degradation of NLRP3. Nat. Commun., 7, 2016, 13727.
227. Stapleton, N.M., et al. Competition for FcRn-mediated transport gives rise to short half-life of human IgG3 and offers therapeutic potential. Nat. Commun., 2, 2011, 599.
228. Stein, S.C., Falck-Pedersen, E., Sensing adenovirus infection: activation of interferon regulatory factor 3 in RAW 264.7 cells. J. Virol. 86 (2012), 4527–4537.
229. Stremlau, M., et al. The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys. Nature 427 (2004), 848–853.
230. Stremlau, M., et al. Specific recognition and accelerated uncoating of retroviral capsids by the TRIM5 restriction factor. Proc. Natl. Acad. Sci. U.S.A. 103 (2006), 5514–5519.
231. Sun, Z., Ren, H., Liu, Y., Teeling, J.L., Gu, J., Phosphorylation of RIG-I by casein kinase II inhibits its antiviral response. J. Virol. 85 (2011), 1036–1047.
232. Sun, L., Wu, J., Du, F., Chen, X., Chen, Z.J., Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type-I interferon pathway. Science 257 (2013), 2432–2437.
233. Sun, X., et al. A hierarchical mechanism of RIG-I ubiquitination provides sensitivity, robustness and synergy in antiviral immune responses. Sci. Rep., 6, 2016, 29263.
234. Tabah, A.A., Tardif, K., Mansky, L.M., Anti-HIV-1 activity of trim 37. J. Gen. Virol. 95 (2014), 960–967.
235. Takeda, K., Akira, S., Toll-like receptors in innate immunity. Int. Immunol. 17 (2005), 1–14.
236. Tassaneetrithep, B., et al. DC-SIGN (CD209) mediates dengue virus infection of human dendritic cells. J. Exp. Med. 197 (2003), 823–829.
237. Tatematsu, M., Nishikawa, F., Seya, T., Matsumoto, M., Toll-like receptor 3 recognizes incomplete stem structures in single-stranded viral RNA. Nat. Commun., 4, 2013, 1833.
238. Tatematsu, M., Seya, T., Matsumoto, M., Beyond dsRNA: toll-like receptor 3 signalling in RNA-induced immune responses. Biochem. J. 458 (2014), 195–201.
239. Taylor, R.T., et al. TRIM79α an interferon-stimulated gene product, restricts tick-borne encephalitis virus replication by degrading the viral RNA polymerase. Cell Host Microbe 10 (2012), 185–196.
240. Thompson, M.R., Kaminski, J.J., Kurt-Jones, E.A., Fitzgerald, K.A., Pattern recognition receptors and the innate immune response to viral infection. Virus 3 (2011), 920–940.
241. Tomar, D., Singh, R., TRIM13 regulates ubiquitination and turnover of NEMO to suppress TNF induced NF-κB activation. Cell. Signal. 26 (2014), 2606–2613.
242. Triantafilou, K., et al. Human cardiac inflammatory responses triggered by coxsackie B viruses are mainly toll-like receptor (TLR) 8-dependent. Cell. Microbiol. 7 (2005), 1117–1126.
243. Tsuchida, T., et al. The ubiquitin ligase TRIM56 regulates innate immune responses to intracellular double-stranded DNA. Immunity 33 (2010), 765–776.
244. Turelli, P., et al. Cytoplasmic recruitment of INI1 and PML on incoming HIV preintegration complexes: interference with early steps of viral replication. Mol. Cell 7 (2001), 1245–1254.
245. Turrini, F., et al. HIV-1 transcriptional silencing caused by TRIM22 inhibition of Sp1 binding to the viral promoter. Retrovirology, 12, 2015, 104.
246. Uchil, P.D., Quinlan, B.D., Chan, W.T., Luna, J.M., Mothes, W., TRIM E3 ligases interfere with early and late stages of the retroviral life cycle. PLoS Pathog., 4(2), 2008, e16, 10.1371/journal.ppat.0040016.
247. Uchil, P.D., et al. TRIM protein-mediated regulation of inflammatory and innate immune signaling and its association with antiretroviral activity. J. Virol. 87 (2013), 257–272.
248. Unterholzner, L., et al. IFI16 is an innate immune sensor for intracellular DNA. Nat. Immunol. 11 (2010), 997–1004.
249. Vajjhala, P.R., et al. Identification of multifaceted binding modes for pyrin and ASC pyrin domains gives insights into pyrin inflammasome assembly. J. Biol. Chem. 289 (2014), 23504–23519.
250. Vance, R.E., Cytosolic DNA sensing: the field narrows. Immunity 45 (2016), 227–228.
251. Vaysburd, M., et al. Intracellular antibody receptor TRIM21 prevents fatal viral infection. Proc. Natl. Acad. Sci. U.S.A. 110 (2013), 12397–12401.
252. Villano, J.S., Rong, F., Cooper, T.K., Bacterial infections in Myd88-deficient mice. Comp. Med. 64 (2014), 110–114.
253. Wagenknecht, N., et al. Contribution of the major ND10 proteins PML, hDaxx and sp100 to the regulation of human cytomegalovirus latency and lytic replication in the monocytic cell line THP-1. Virus 7 (2015), 2884–2907.
254. Wagner, J.M., et al. Mechanism of B-box 2 domain-mediated higher-order assembly of the retroviral restriction factor TRIM5α. eLife 5 (2016), 1–26.
255. Wang, C.H., et al. TLR7 and TLR8 gene variations and susceptibility to hepatitis C virus infection. PLoS One 6 (2011), 6–13.
256. Wang, J., et al. TRIM56 is a virus- and interferon-inducible E3 ubiquitin ligase that restricts pestivirus infection. J. Virol. 85 (2011), 3733–3745.
257. Wang, X., et al. RNA viruses promote activation of the NLRP3 inflammasome through a RIP1-RIP3-DRP1 signaling pathway. Nat. Immunol. 15 (2014), 1126–1133.
258. Wang, P., Zhao, W., Zhao, K., Zhang, L., Gao, C., TRIM26 negatively regulates interferon beta production and antiviral response through polyubiquitination and degradation of nuclear IRF3. PLoS Pathog., 11, 2015, e1004726.
259. Wang, Y., et al. TRIM35 negatively regulates TLR7- and TLR9-mediated type I interferon production by targeting IRF7. FEBS Lett. 589 (2015), 1322–1330.
260. Wang, S., et al. TRIM14 inhibits hepatitis C virus infection by SPRY domain-dependent targeted degradation of the viral NS5A protein. Sci. Rep., 6, 2016, 32336.
261. Watkinson, R.E., Tam, J.C., Vaysburd, M.J., James, L.C., Simultaneous neutralization and innate immune detection of a replicating virus by TRIM21. J. Virol. 87 (2013), 7309–7313.
262. Watkinson, R.E., McEwan, W.A., Tam, J.C.H., Vaysburd, M., James, L.C., TRIM21 promotes cGAS and RIG-I sensing of viral genomes during infection by antibody-opsonized virus. PLoS Pathog., 11(10), 2015, e1005253, 10.1371/journal.ppat.1005253.
263. Weng, L., et al. The E3 ubiquitin ligase tripartite motif 33 is essential for cytosolic RNA-induced NLRP3 inflammasome activation. J. Immunol. 193 (2014), 3676–3682.
264. Wies, E., Wang, M.K., Maharaj, N.P., Chen, K., Shenghua Zhou, R., Finberg, W., Gack, M.U., Dephosphorylation of the RNA sensors RIG-I and MDA5 by the phosphatase PP1 is essential for innate immune signaling. Immunity 38 (2013), 437–449.
265. Wilson, S.J., et al. Independent evolution of an antiviral TRIMCyp in rhesus macaques. Proc. Natl. Acad. Sci. U.S.A. 105 (2008), 3557–3562.
266. Wolf, D., Goff, S.P., TRIM28 mediates primer binding site-targeted silencing of murine leukemia virus in embryonic cells. Cell 131 (2007), 46–57.
267. Wu, X., Anderson, J.L., Campbell, E.M., Joseph, A.M., Hope, T.J., Proteasome inhibitors uncouple rhesus TRIM5alpha restriction of HIV-1 reverse transcription and infection. Proc. Natl. Acad. Sci. U.S.A. 103 (2006), 7465–7470.
268. Wu, B., et al. Structural basis for dsRNA recognition, filament formation, and antiviral signal activation by MDA5. Cell 152 (2013), 276–289.
269. Wu, J., Sun, L., Chen, X., Du, F., Shi, H., Chen, C., Chen, Z.J., Cyclic-GMP-AMP is an endogenous second messenger in innate immune signaling by cytosolic DNA. Science 339 (2013), 826–830.
270. Wynne, C., et al. TRIM68 negatively regulates IFN beta production by degrading TRK fused gene, a novel driver of IFN beta downstream of anti-viral detection systems. PLoS One, 9(7), 2014, e101503.
271. Xia, X., Cui, J., Wang, H.Y., Liang, Z., Matsueda, S., Wang, Q., Yang, X., Hong, J., Songyang, Z., Chen, Z.J., Wang, R.-F., NLRX1 negatively regulates TLR-induced NF-κB signaling by targeting. Immunity 34 (2011), 843–853.
272. Xing, J., et al. Identification of a role for TRIM29 in the control of innate immunity in the respiratory tract. Nat. Immunol. 17 (2016), 1373–1380.
273. Xu, H., et al. Innate immune sensing of bacterial modifications of Rho GTPases by the Pyrin inflammasome. Nature 513 (2014), 237–241.
274. Xue, Q., et al. TRIM38 negatively regulates TLR3-mediated IFN-β signaling by targeting TRIF for degradation. PLoS One, 7(10), 2012, e46825.
275. Yan, J., Li, Q., Mao, A., Hu, M., Shu, H., TRIM 4 modulates type I interferon induction and cellular antiviral response by targeting RIG-I for K 63-linked ubiquitination. J. Mol. Cell Biol. 6 (2014), 154–163.
276. Yang, K., et al. TRIM21 is essential to sustain IFN regulatory factor 3 activation during antiviral response. J. Immunol. 182 (2009), 3782–3792.
277. Yang, B., et al. Novel function of Trim44 promotes an antiviral response by stabilizing VISA. J. Immunol. 190 (2013), 3613–3619.
278. Yang, C., et al. Interferon alpha (IFNα)-induced TRIM22 interrupts HCV replication by ubiquitinating NS5A. Cell. Mol. Immunol. 13 (2016), 94–102.
279. Yap, M.W., Nisole, S., Lynch, C., Stoye, J.P., Trim5alpha protein restricts both HIV-1 and murine leukemia virus. Proc. Natl. Acad. Sci. U.S.A. 101 (2004), 10786–10791.
280. Yoshimi, R., et al. Gene disruption study reveals a non-redundant role for TRIM21/Ro52 in NF-κB-dependent cytokine expression in fibroblasts. J. Immunol. 182 (2010), 7527–7538.
281. Yu, J.-W., et al. Cryopyrin and pyrin activate caspase-1, but not NF-κB, via ASC oligomerization. Cell Death Differ. 13 (2006), 236–249.
282. Yuan, T., Yao, W., Huang, F., Sun, B., Yang, R., The human antiviral factor TRIM11 is under the regulation of HIV-1 Vpr. PLoS One, 9(8), 2014, e104269, 10.1371/journal.pone.0104269.
283. Yuan, T., Yao, W., Tokunaga, K., Yang, R., Sun, B., An HIV-1 capsid binding protein TRIM11 accelerates viral uncoating. Retrovirology, 13, 2016, 72.
284. Zeng, W., et al. Reconstitution of the RIG-I pathway reveals a signaling role of unanchored polyubiquitin chains in innate immunity. Cell 141 (2010), 315–330.
285. Zhang, Z., et al. The E3 ubiquitin ligase TRIM21 negatively regulates the innate immune response to intracellular double-stranded DNA. Nat. Immunol. 14 (2012), 172–178.
286. Zhang, J., Hu, M.M., Wang, Y.Y., Shu, H.B., TRIM32 protein modulates type I interferon induction and cellular antiviral response by targeting MITA/STING protein for K63-linked ubiquitination. J. Biol. Chem. 287 (2012), 28646–28655.
287. Zhang, S., Guo, J.T., Wu, J.Z., Yang, G., Identification and characterization of multiple TRIM proteins that inhibit hepatitis B virus transcription. PLoS One, 8(8), 2013, e70001, 10.1371/journal.pone.0070001.
288. Zhao, Y., Shao, F., The NAIP-NLRC4 inflammasome in innate immune detection of bacterial flagellin and type III secretion apparatus. Immunol. Rev. 265 (2015), 85–102.
289. Zhao, Y., et al. The NLRC4 inflammasome receptors for bacterial flagellin and type III secretion apparatus. Nature 477 (2011), 596–600.
290. Zhao, W., Wang, L., Zhang, M., Yuan, C., Gao, C., E3 ubiquitin ligase tripartite motif 38 negatively regulates TLR-mediated immune responses by proteasomal degradation of TNF receptor-associated factor 6 in macrophages. J. Immunol. 188 (2012), 2567–2574.
291. Zhao, W., et al. Tripartite motif-containing protein 38 negatively regulates TLR3/4- and RIG-I-mediated IFN- production and antiviral response by targeting NAP1. J. Immunol. 188 (2012), 5311–5318.
292. Zheng, X., et al. TRIM25 is required for the antiviral activity of zinc-finger antiviral protein (ZAP). J. Virol. 91 (2017), JVI.00088–17.
293. Zhou, Z., et al. TRIM14 is a mitochondrial adaptor that facilitates retinoic acid-inducible gene-I-like receptor-mediated innate immune response. Proc. Natl. Acad. Sci. U.S.A. 111 (2014), E245–E254.
294. Zhu, J., Huang, X., Yang, Y., Innate immune response to adenoviral vectors is mediated by both toll-like receptor-dependent and -independent pathways. J. Virol. 81 (2007), 3170–3180.
295. Zhu, J., Zhang, Y., Ghosh, A., Cuevas, R.A., Forero, A., Dhar, J., Ibsen, M.S., Schmid-Burgk, J.L., Schmidt, T., Ganapathiraju, M.K., Fujita, T., Hartmann, R., Barik, S., Hornung, V., Coyne, C.B., Sarkar, S.N., Antiviral activity of human oligoadenylate synthetases-like (OASL) is mediated by enhancing retinoic acid-inducible gene I (RIG-I) signaling. Immunity 40 (2014), 936–948.
296. Zhu, J., Ghosh, A., Sarkar, S.N., OASL—a new player in controlling antiviral innate immunity. Curr. Opin. Virol. 12 (2015), 15–19.
297. Zurek, B., et al. TRIM27 negatively regulates NOD2 by ubiquitination and proteasomal degradation. PLoS One, 7(7), 2012, e41255, 10.1371/journal.pone.0041255.